Dicerna Pharmaceuticals Inc (DRNA) - Financial Analysis Review

Summary

Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that offers discovery and development of innovative treatments. The company discovers and develops treatments for rare inherited diseases involving the liver and for cancers that are genetically defined. Its product pipeline is being generated from the companys proprietary RNA interference. Dicernas product pipeline comprises DCR-PH1, KRAS Program, primary hyperoxaluria 1 and hepatocellular carcinoma. The company provides RNAi-targeted drugs, delivery systems and DsiRNA molecules. It also offers traditional therapeutic modalities, such as small molecules and monoclonal antibodies.

GlobalData's Dicerna Pharmaceuticals Inc (DRNA) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Dicerna Pharmaceuticals Inc Key Recent Developments:

Nov 07,2016: Dicerna Reports Third Quarter 2016 Financial and Operational Results
Sep 26,2016: Dicerna Prioritizes Resources to Advance GalXC Product Candidates
Aug 04,2016: Dicerna Reports Second Quarter 2016 Financial and Operational Results
Jun 29,2016: New Preclinical Data Show Potential of Dicerna GalXC Subcutaneous Delivery Platform as RNAi Drug Discovery Engine
Jun 15,2016: Dicerna Appoints Martin Freed, M.D., to Board of Directors


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.